FinDisc: A prospective, randomized, placebo-surgery controlled trial on the efficacy of microdiscectomy surgery for lumbar disc herniation
Description of the granted funding
Although microdiscectomy for lumbar disc herniation is one of the most commonly performed spinal surgical procedures, the evidence on its' efficacy is limited. FinDisc will be the first randomised placebo-controlled trial of microdiscectomy for patients with pain persisting over 6 weeks. 122 patients will be recruited and undergo either microdiscectomy or placebo-surgery. The placebo intervention will resemble microdiscectomy but exclude procedures to alleviate the compression over the nerve root (i.e., removal of the herniated disc material and other tissues potentially compressing the nerve root) Participants, caregivers, and researchers will be blinded to treatment allocation over the entire course of the trial. The findings of this study will provide high certainty evidence for the efficacy of microdiscectomy.
Show moreStarting year
2021
End year
2025
Granted funding
Other information
Funding decision number
339597
Research fields
Kliiniset lääketieteet
Identified topics
intensive care, anesthesiology, radiology